supply of e-30 anticancer - inj. 5 fluorouracil 250mg, inj. azacitidine 100 mg, inj. albumin bound paclitaxel 100 m, inj. bendamustine 100mg, inj. bevacizumab 400mg, inj. bevacizumab 100mg, inj. bleomycin 15mg, inj. bortezomib 2mg, inj. carboplatin 150mg, inj. carboplatin 450mg, inj. cisplatin 10, inj. cisplatin 50, inj. cytarabine 100mg, inj. carfilzomib 60mg, inj. dacarbazine 200mg, inj. daunorubicin 20mg, inj. docetaxel 20mg rtu, inj. docetaxel 80mg rtu, inj. dostarlimab, inj. doxorubicin 1

Department Of Medical Education And Research has invited bids for the supply of e-30 anticancer - inj. 5 fluorouracil 250mg, inj. azacitidine 100 mg, inj. albumin bound paclitaxel 100 m, inj. bendamustine 100mg, inj. bevacizumab 400mg, inj. bevacizumab 100mg, inj. bleomycin 15mg, inj. bortezomib 2mg, inj. carboplatin 150mg, inj. carboplatin 450mg, inj. cisplatin 10, inj. cisplatin 50, inj. cytarabine 100mg, inj. carfilzomib 60mg, inj. dacarbazine 200mg, inj. daunorubicin 20mg, inj. docetaxel 20mg rtu, inj. docetaxel 80mg rtu, inj. dostarlimab, inj. doxorubicin 10mg, inj. doxorubicin 50mg, inj. doxorubicin liposomal 50mg, inj. denosumab 120mg, inj. epirubicin 10, inj. epirubicin 50, inj. etoposide 100mg, inj. fulvestrant 250mg, inj. filgrastin 300mcg, inj. gemcitabine 1gm, inj. gemcitabine 200mg, inj. herpes zoster vaccine, inj. (peg-gcsf 6 mg), inj. ifosfamide 1 gm, inj. irinotecan 100mg, inj. l-asparaginase 10000iu, inj. l-asparaginase 5000iu, inj. leucovorin (folinic acid) 50 mg, inj. leuprolide acetate 22.5 mg, inj. mepolizumab, inj. methotrexate 50mg, inj. methotrexate 500mg, inj. nanosomal docetaxel lipid, suspension for injection 20 mg, inj. nanosomal docetaxel lipid, suspension for injection 80 mg, inj. nanosomal paclitaxel lipid, suspension for injection 30 mg, inj. nanosomal paclitaxel lipid, suspension for injection 100 mg, inj. oxaliplatin 100mg, inj. oxaliplatin 50mg, inj. paclitaxel 260mg, inj. paclitaxel 30mg, inj. peg-asparginase 3750 iu, inj. pemetrexed 500mg, inj. pertuzumab infusion 420 mg, inj. rituximab 100mg, inj. rituximab 500mg, inj. serplulimab infusion 100 mg, inj. trastuzumab 150 mg, inj. trastuzumab 375 mg, inj. trastuzumab 440 mg, inj. vinorelbine 50mg, inj. vincristine 1mg, inj. zoledronic acid 4mg, tab. 6 mercaptopurine 50mg, tab. abiraterone acetate 250mg, tab. anastrozole 1 mg, tab. azacitidine 200 mg, tab. bicalutamide 50mg, tab. capecitabine 500mg, tab. capecitabine (400mg) +, cyclophosphamide (20mg), tab. capecitabine (700mg) +, cyclophosphamide (30mg), tab. cyclophosphamide 50mg, tab. dasatinib 50mg, tab. erlotinib 100mg, tab. etoposide 50mg, tab. eltrombopag 25mg, tab. eltrombopag 50 mg, tab. eltrombopag 75 mg, cap. enzalutamide 40 mg, cap. enzalutamide 80 mg, cap. enzalutamide 160 mg, tab. gefitinib 250mg, tab. imatinib 400mg, tab. lenvatinib 4 mg, tab. lapatinib 250mg, tab. letrozole 2.5mg, tab. nilotinib 200mg, tab. niraparib, tab. olaparib 100 mg, tab. olaparib 150 mg, tab. pazopanib 400mg, tab. regorafenib 40mg, tab. sorafenib 200 mg, tab. sunitib malate 25mg, tab. sunitib malate 12.5mg, cap. temozolamide 100mg, cap. temozolamide 250mg, cap. palbociclib 125mg, tab. cabozantinib 20mg, cap. acalabrutinib 100mg. The estimated project cost is ₹10.43 Cr, with an EMD of ₹0.11 Cr. Interested bidders can submit applications until 6 October 2026, with the technical opening scheduled for 7 October 2026.